These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16820368)

  • 21. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticoagulation to prevent stroke in atrial fibrillation. It's still not clear whether results in secondary care translate to primary care.
    Fitzmaurice DA; Mant J; Murray ET; Hobbs FD
    BMJ; 2000 Nov; 321(7269):1156. PubMed ID: 11203222
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulation to prevent stroke in atrial fibrillation. Rapid anticoagulant testing is not available in general practitioners' clinics in Japan.
    Onu A
    BMJ; 2000 Nov; 321(7269):1157. PubMed ID: 11061750
    [No Abstract]   [Full Text] [Related]  

  • 25. The challenge of preventing stroke in elderly patients with atrial fibrillation.
    Boriani G; Biffi M; Diemberger I; Ziacchi M; Martignani C
    J Cardiovasc Electrophysiol; 2011 Jan; 22(1):31-3. PubMed ID: 20812926
    [No Abstract]   [Full Text] [Related]  

  • 26. Anticoagulation therapy for stroke.
    Ashraf H
    Drug Discov Today; 2005 Aug; 10(16):1077. PubMed ID: 16182190
    [No Abstract]   [Full Text] [Related]  

  • 27. New therapies for stroke prevention in atrial fibrillation: the long road to enhanced efficacy.
    Freedman JE; Gersh BJ
    Circulation; 2009 Sep; 120(12):1024-6. PubMed ID: 19738132
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticoagulation for patients with atrial fibrillation in ambulatory care settings.
    Niska R; Han B
    J Am Board Fam Med; 2009; 22(3):299-306. PubMed ID: 19429736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.
    Taggar JS; Lip GY
    Europace; 2008 Jan; 10(1):1-2. PubMed ID: 17906285
    [No Abstract]   [Full Text] [Related]  

  • 31. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 33. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes.
    Nieuwlaat R; Connolly SJ
    Heart; 2009 Feb; 95(2):95-7. PubMed ID: 18952632
    [No Abstract]   [Full Text] [Related]  

  • 37. New device for stroke prevention in atrial fibrillation as an alternative to anticoagulation drugs.
    Lobodzinski SS
    Cardiol J; 2009; 16(4):375-8. PubMed ID: 19653186
    [No Abstract]   [Full Text] [Related]  

  • 38. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.